ATE473737T1 - Verwendung von 2,3-dehydronaringenin-derivaten zur behandlung von entzündungsprozessen und diese derivate enthaltende pharmazeutische zusammensetzung - Google Patents

Verwendung von 2,3-dehydronaringenin-derivaten zur behandlung von entzündungsprozessen und diese derivate enthaltende pharmazeutische zusammensetzung

Info

Publication number
ATE473737T1
ATE473737T1 AT04380155T AT04380155T ATE473737T1 AT E473737 T1 ATE473737 T1 AT E473737T1 AT 04380155 T AT04380155 T AT 04380155T AT 04380155 T AT04380155 T AT 04380155T AT E473737 T1 ATE473737 T1 AT E473737T1
Authority
AT
Austria
Prior art keywords
derivatives
inflammatory processes
treatment
pharmaceutical composition
composition containing
Prior art date
Application number
AT04380155T
Other languages
English (en)
Inventor
Salinas Juan Lorente
Sanchez Julian Castillo
Garcia Obdulio Benavente-Garcia
Ortega Vicente Vicente
Gascon Josefa Yanez
Munoz Francisco Solano
Banos Miguel Alcaraz
Borron Jose Carlos Garcia
Teruel Jose Antonio Lozano
Original Assignee
Furfural Espanol S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Furfural Espanol S A filed Critical Furfural Espanol S A
Application granted granted Critical
Publication of ATE473737T1 publication Critical patent/ATE473737T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
AT04380155T 2004-07-20 2004-07-20 Verwendung von 2,3-dehydronaringenin-derivaten zur behandlung von entzündungsprozessen und diese derivate enthaltende pharmazeutische zusammensetzung ATE473737T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP04380155A EP1618880B1 (de) 2004-07-20 2004-07-20 Verwendung von 2,3-Dehydronaringenin-Derivaten zur Behandlung von Entzündungsprozessen und diese Derivate enthaltende pharmazeutische Zusammensetzung

Publications (1)

Publication Number Publication Date
ATE473737T1 true ATE473737T1 (de) 2010-07-15

Family

ID=34931855

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04380155T ATE473737T1 (de) 2004-07-20 2004-07-20 Verwendung von 2,3-dehydronaringenin-derivaten zur behandlung von entzündungsprozessen und diese derivate enthaltende pharmazeutische zusammensetzung

Country Status (6)

Country Link
US (1) US20060020021A1 (de)
EP (1) EP1618880B1 (de)
AT (1) ATE473737T1 (de)
CA (1) CA2512531A1 (de)
DE (1) DE602004028113D1 (de)
ES (1) ES2353001T3 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080103103A1 (en) * 2006-10-30 2008-05-01 Bahram Memarzadeh Reagents and methods to treat ocular diseases and infection
KR20110106355A (ko) * 2008-12-11 2011-09-28 악센투아 파마슈투칼스 아베 제니스테인의 결정성 형태

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0725761A (ja) * 1993-07-09 1995-01-27 Kureha Chem Ind Co Ltd 軟骨保護剤
JPH08104628A (ja) * 1994-10-04 1996-04-23 Sumitomo Pharmaceut Co Ltd マトリックスメタロプロテアーゼ阻害剤
IN186803B (de) * 1997-02-05 2001-11-10 Panacea Biotec Ltd

Also Published As

Publication number Publication date
CA2512531A1 (en) 2006-01-20
EP1618880B1 (de) 2010-07-14
DE602004028113D1 (de) 2010-08-26
ES2353001T3 (es) 2011-02-24
EP1618880A1 (de) 2006-01-25
US20060020021A1 (en) 2006-01-26

Similar Documents

Publication Publication Date Title
ATE417610T1 (de) Zusammensetzung enthaltend 6-ä3-(1-adamantyl)-4- methoxyphenylü-2-naphthanoesäure zur behandlung dermatologischer erkrankungen
EA200900136A1 (ru) Пирролопиримидины для фармацевтических композиций
EA201071045A1 (ru) Соединения оксадиазоантрацена для лечения диабета
SE0303180D0 (sv) Novel compounds
SE0302232D0 (sv) Novel Compounds
IL196543A (en) Pyridazinone derivatives, pharmaceutical preparations containing them for use in the treatment of disorders
ATE453636T1 (de) Substituierte 2,3-dihydro-1h-isoindol-1-one derivate und anwendungsverfahren
ATE517882T1 (de) Chinolinderivate
MXPA03011484A (es) Heteroarilos multiciclicos sustituidos con quinuclidinas para el tratamiento de enfermedades.
CY1107956T1 (el) Χρηση υποκατεστημενων 2-αμινοτετραλινιων για την προληπτικη αντιμετωπιση της νοσου του παρκινσον
TW200728305A (en) Spiropiperidine beta-sectetase inhibitors for the treatment of alzheimer's disease
SE0403006D0 (sv) New compounds
NO20082096L (no) Azaindol-2-karboksamidderivativer
EA200802223A1 (ru) 1,5-дифенилпиразолы ii в качестве ингибиторов hsp90
ATE538651T1 (de) Spiropiperidininhibitoren von beta-secretase zur behandlung von alzheimer-krankheit
EA200970065A1 (ru) Производные пиперазинила, предназначенные для лечения заболеваний, опосредованных рецептором gpr38
NO20076405L (no) Anvendelse av 24-nor-UDCA
BRPI0508051A (pt) derivados de heteroarilaminopirazol utilizáveis para o tratamento de diabetes
BR0316723A (pt) Derivados de anilinopirazol úteis para o tratamento de diabetes
ATE432278T1 (de) Verbindungen zur behandlung von krankheiten
DE602006003415D1 (de) 3,11b-cis-dihydrotetrabenazin zur behandlung von proliferativen krankheiten oder entzündungen
DE602006010738D1 (de) Pyrroloä2,3-cüpyridinderivate
DE602005014632D1 (de) Pyrrol- bzw. imidazolamide zur behandlung von obesitas
EA200600115A1 (ru) Производные 2-аминобензойной кислоты
EA200700707A1 (ru) Производные 2-ациламинотиазола

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties